As of December 31, 2025, HOMEBIOGAS LTD carries a market capitalization of 3.83B, placing it among publicly traded companies globally. Its enterprise value stands at 3.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.83B |
| Enterprise Value | 3.39B |
As of December 31, 2025, HOMEBIOGAS LTD has 28.34M shares outstanding.
| Shares Outstanding | 28.34M |
These figures are as of December 31, 2025.
| PB Ratio | 4.42 |
| P/TBV Ratio | 4.42 |
As of December 31, 2025, HOMEBIOGAS LTD maintains a current ratio of 2.13, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.13 |
| Quick Ratio | 0.99 |
| Debt / Equity | 13.99 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 16.50 |
As of the close on October 22, 2026, HOMEBIOGAS LTD's stock has declined approximately 42.97% over the past 52 weeks. The 50-day moving average sits at 80.83, while the 200-day moving average is 81.85.
| 52-Week Price Change | -42.97% |
| 50-Day Moving Average | 80.83 |
| 200-Day Moving Average | 81.85 |
As of December 31, 2025, HOMEBIOGAS LTD holds 590.48M in cash and equivalents against 123.99M in total debt, resulting in a net debt position of -590.48M. Total book value stands at 868.27M, with working capital of 672.29M providing operational flexibility.
| Cash & Cash Equivalents | 590.48M |
| Total Debt | 123.99M |
| Net Debt | -590.48M |
| Equity (Book Value) | 868.27M |
| Book Value Per Share | 30.64 |
| Working Capital | 672.29M |
Already premium?